Regenxbio (RGNX) Receivables - Other (2014 - 2026)

Regenxbio's Receivables - Other history runs 10 years deep, the most recent figure standing at $10.9 million for Q4 2025.

• In Q4 2025, Receivables - Other fell 3.57% year-over-year to $10.9 million; the TTM figure through Dec 2025 stood at $10.9 million (down 3.57% YoY), while the FY2025 annual figure was $10.9 million, down 45.79% from the prior year.
• Receivables - Other for Q4 2025 stood at $10.9 million, down from $22.8 million in the prior quarter.
• The five-year high for Receivables - Other was $33.5 million in Q2 2022, with the low at $28000.0 in Q2 2025.
• The 5-year median for Receivables - Other is $5.6 million (2022), against an average of $10.8 million.
• Peak annual rise in Receivables - Other reached 8688.03% in 2025, while the deepest fall reached 99.71% in 2025.
• Regenxbio's Receivables - Other stood at $1.1 million in 2021, then jumped by 486.03% to $6.3 million in 2022, then declined by 20.56% to $5.0 million in 2023, then jumped by 126.08% to $11.3 million in 2024, then slipped by 3.57% to $10.9 million in 2025.
• Business Quant data shows RGNX's Receivables - Other at $10.9 million in Q4 2025, $22.8 million in Q3 2025, and $28000.0 in Q2 2025.